Yimei Chen

Yimei Chen

Auto-generated profile, based on publicly available information

Yimei Chen

Physical Examination Center, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 October 2022 in Disease Markers
Verified
Journal Article
Open access
PDF file
SHSicong Huang
Sicong Huang
YCYi-Mei Chen
Yi-Mei Chen
YHYing-Yu Hu
Ying-Yu Hu
YSYong-Jie Shi
Yong-Jie Shi
QXQi-Wen Xiao
Qi-Wen Xiao
HJHong-Yun Jia
Hong-Yun Jia
Backgound. Multiple patients with hepatocellular carcinoma (HCC) received sorafenib therapy presented primary or secondary chemoresistance. The underlying mechanisms of chemoresistance are rather vague, ferroptosis is a new kind of cell death, and its discovery provides new opportunities to overcome sorafenib resistance. Therefore, it is essential to investigate the regulators of ferroptosis and implement a corresponding therapy strategy. Methods and Results. The levels of MCF2L were detected by PCR and western blotting assay. The effect of MCF2L on ferroptosis was confirmed by MTT, colony formation assay, Brdu, in vivo animal experiment, and the content of Iron, GSH, ROS, and MDA. The underlying mechanisms were explored by PCR, western blotting, and affinity precipitation assay. Our findings demonstrated that MCF2L is remarkedly upregulated in HCC tissues, and sorafenib can induce the levels of MCF2L, suggesting that MCF2L might function in sorafenib resistance of HCC. Further analysis showed that downregulation of MCF2L enhances HCC cell death induced by sorafenib, and ferroptosis inhibitor can reverse this process. Subsequent experiments showed that downregulation of MCF2L elevates the content of Iron, ROS, and MDA, which are all indicators of ferroptosis. Finally, mechanism analysis showed that MCF2L regulates the PI3K/AKT pathway in a RhoA/Rac1 dependent manner. Conclusions. Our study showed that targeting MCF2L may be a hopeful method to overcome sorafenib-resistance through inducing ferroptosis in HCC.

11 October 2024 in Medicine
Verified
Journal Article
Open access
WJWu People's Juan
Wu People's Juan
JHJiefeng Bm Huang
Jiefeng Bm Huang
MHMiaoling Bm Hong
Miaoling Bm Hong
LXLi Bm Xia
Li Bm Xia
YLYuye Bm Lin
Yuye Bm Lin
XHXudong Huang
Xudong Huang
Insulin resistance is a key factor in diabetes development. This study aimed to investigate the association between baseline triglyceride–glucose (TyG) index, a surrogate marker of insulin resistance, and the onset of hyperglycemia in Chinese individuals with hypertension. Using the Rich Healthcare Group database, this retrospective cohort study included 28,687 hypertensive individuals without preexisting diabetes. A wide range of demographic information and baseline biochemical indicators was collected and rigorously analyzed. This study utilized the Cox proportional hazards model and smooth curve fitting to explore the link between TyG index and the risk of developing hyperglycemia. The robustness of the findings was validated by sensitivity and subgroup analyses. During longitudinal monitoring of hypertensive patients in our retrospective cohort study, we observed that 5.31% (1524/28,687) progressed to diabetes, while 21.66% (4620/21,326) developed prediabetes. After adjusting for confounding variables, a statistically significant positive association was observed between the TyG index and the risk of hyperglycemia. Subgroup and sensitivity analyses further supported these findings, demonstrating consistent outcomes and reinforcing the robustness of our conclusions. The TyG index, which is significantly linked to hyperglycemia in hypertensives, can aid early risk identification and intervention.

29 July 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
YSYongjie Shi
Yongjie Shi
QXQiwen Xiao
Qiwen Xiao
WXWeichun Xiao
Weichun Xiao
JKJiale Kang
Jiale Kang
QZQiang Zhou
Qiang Zhou
SHSicong Huang
Sicong Huang
Hepatocellular carcinoma (HCC) is frequently associated with Yeats-domain containing 2 (YEATS2) overexpression, which enhances tumor progression via the PI3K/AKT pathway. Our study delineates YEATS2’s oncogenic functions in HCC and its potential as a prognostic and predictive biomarker. Through comprehensive in vitro and bioinformatics analyses, we reveal that YEATS2 promotes cell proliferation, invasion, and epithelial-mesenchymal transition (EMT). Additionally, YEATS2 modulates the tumor immune microenvironment and predicts response to immunotherapies and chemotherapies. YEATS2’s serum stability suggests its utility as a non-invasive biomarker for personalized HCC treatment.